• Home
  • News
  • Coins2Day 500
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
    • Great Place To Work
  • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Success
    • Future Of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Home
  • News
  • Coins2Day 500
    • Coins2Day 500
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
    • Great Place To Work
  • Tech
    • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Leadership
    • Success
    • Future Of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Rankings
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Asia
  • Europe
  • Analytics

Sy Mukherjee

Sy Mukherjee is a former health care reporter for Coins2Day.

    Page 24 of 100

  • Pentagon DNA Test Kits WarningHealth

    Pentagon Latest to Warn About Concerns Around DNA Test Kits

    By Market Analyst
  • Sarepta Stock Roche DealHealth

    Controversial Biotech Sarepta Keeps Up Unlikely Win Streak With $1.15 Billion Roche Deal

    By Industry Analyst
  • Brainstorm Health 2020 SignoffNewsletters

    A Holiday Reflection and Temporary Farewell

    By Research Team
  • Healthcare Ideas 2020sNewsletters

    The Ideas That Will Shape Health Care in the Next Decade

    By Trading Desk
  • Big Pharma ROINewsletters

    Big Pharma’s Return on Investment Plummets to a Dismal 10-Year Low

    By Research Team
  • Multiple myeloma MMRFNewsletters

    GlaxoSmithKline Hopes to Take on Rivals With Rare Blood Cancer Drug

    By Senior Editor
  • Drugs and Tech Revolutionizinf HealthcareHealth

    The 4 Most Game-Changing Medical Advances of the Past Decade

    By Financial Writer
  • Vaping E-Cig Lung Respiratory Illness StudyNewsletters

    A New Study Shows the Damage Just 3 Years of Vaping Could Do to Your Lungs

    By Research Team
  • Duchenne Sarepta FDANewsletters

    FDA Approves Sarepta Duchenne Drug in Stunning Reversal

    By Tech Reporter
  • Stephen Hahn FDA Commissioner ConfirmedNewsletters

    Meet Stephen Hahn, the New FDA Commissioner

    By Industry Analyst
  • Fertility Business MPW Next GenConferences

    The 3 Things That Have Been Holding Back the Fertility Business

    By Senior Editor
  • Home Depot Theft Opioid CrisisNewsletters

    Is Loneliness Driving the Opioid Epidemic?

    By Senior Editor
  • Flu Season 2020Newsletters

    Flu Season Came Early. Here’s What You Should Do

    By Contributing Writer
  • CVS CEO Larry Merlo Aetna Deal InterviewNewsletters

    CVS CEO on What’s Happened After Its Aetna Merger—and What Comes Next

    By Editorial Team
  • Biogen Alzheimers Drug DataNewsletters

    The Broader Implications of Biogen’s Divisive Alzheimer’s Drug

    By Financial Writer
    Rankings
    • 100 Best Companies
    • Coins2Day 500
    • Global 500
    • Coins2Day 500 Europe
    • Most Powerful Women
    • Future 50
    • World’s Most Admired Companies
    • See All Rankings
    Sections
    • Finance
    • Leadership
    • Success
    • Tech
    • Asia
    • Europe
    • Environment
    • Coins2Day Crypto
    • Health
    • Retail
    • Lifestyle
    • Politics
    • Newsletters
    • Magazine
    • Features
    • Commentary
    • MPW
    • CEO Initiative
    • Conferences
    • Personal Finance
    • Education
    Customer Support
    • Frequently Asked Questions
    • Customer Service Portal
    • Privacy Policy
    • Terms of Use
    • Single Issues for Purchase
    • International Print
    Commercial Services
    • Advertising
    • Coins2Day Brand Studio
    • Coins2Day Analytics
    • Coins2Day Conferences
    • Business Development
    About Us
    • About Us
    • Editorial Calendar
    • Press Center
    • Work at Coins2Day
    • Diversity and Inclusion
    • Terms and Conditions
    • Site Map

    © 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.